BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37951977)

  • 21. Prognosis of pulmonary fibrosis presenting with a usual interstitial pneumonia pattern on computed tomography in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-related nephritis: a retrospective single-center study.
    Watanabe T; Minezawa T; Hasegawa M; Goto Y; Okamura T; Sakakibara Y; Niwa Y; Kato A; Hayashi M; Isogai S; Kondo M; Yamamoto N; Hashimoto N; Imaizumi K
    BMC Pulm Med; 2019 Nov; 19(1):194. PubMed ID: 31675941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Value of
    Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
    J Korean Med Sci; 2021 Oct; 36(41):e257. PubMed ID: 34697928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis.
    Ash SY; Harmouche R; Vallejo DL; Villalba JA; Ostridge K; Gunville R; Come CE; Onieva Onieva J; Ross JC; Hunninghake GM; El-Chemaly SY; Doyle TJ; Nardelli P; Sanchez-Ferrero GV; Goldberg HJ; Rosas IO; San Jose Estepar R; Washko GR
    Respir Res; 2017 Mar; 18(1):45. PubMed ID: 28264721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic quantitative computed tomography measurement of longitudinal lung volume loss in interstitial lung diseases.
    Si-Mohamed SA; Nasser M; Colevray M; Nempont O; Lartaud PJ; Vlachomitrou A; Broussaud T; Ahmad K; Traclet J; Cottin V; Boussel L
    Eur Radiol; 2022 Jun; 32(6):4292-4303. PubMed ID: 35029730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of tissue lipidomics and computed tomography pulmonary fat attenuation volume (CT
    O'Callaghan M; Duignan J; Tarling EJ; Waters DK; McStay M; O'Carroll O; Bridges JP; Redente EF; Franciosi AN; McGrath EE; Butler MW; Dodd JD; Fabre A; Murphy DJ; Keane MP; McCarthy C
    Respirology; 2023 Nov; 28(11):1043-1052. PubMed ID: 37642207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary
    Win T; Screaton NJ; Porter JC; Ganeshan B; Maher TM; Fraioli F; Endozo R; Shortman RI; Hurrell L; Holman BF; Thielemans K; Rashidnasab A; Hutton BF; Lukey PT; Flynn A; Ell PJ; Groves AM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):806-815. PubMed ID: 29335764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis.
    Fujikawa T; Kondo S; Saito T; Inoue T; Otake K; Misu S; Sakai H; Ono R; Tomioka H
    Respir Med Res; 2022 Nov; 82():100965. PubMed ID: 36283327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis.
    Mäkelä K; Mäyränpää MI; Sihvo HK; Bergman P; Sutinen E; Ollila H; Kaarteenaho R; Myllärniemi M
    Hum Pathol; 2021 Jan; 107():58-68. PubMed ID: 33161029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
    Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
    BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality.
    Loeh B; Brylski LT; von der Beck D; Seeger W; Krauss E; Bonniaud P; Crestani B; Vancheri C; Wells AU; Markart P; Breithecker A; Guenther A
    Chest; 2019 May; 155(5):972-981. PubMed ID: 30742809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis.
    Enomoto N; Suda T; Kono M; Kaida Y; Hashimoto D; Fujisawa T; Inui N; Nakamura Y; Imokawa S; Funai K; Chida K
    Respir Med; 2013 Oct; 107(10):1608-16. PubMed ID: 23993151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multidimensional index and staging system for idiopathic pulmonary fibrosis.
    Ley B; Ryerson CJ; Vittinghoff E; Ryu JH; Tomassetti S; Lee JS; Poletti V; Buccioli M; Elicker BM; Jones KD; King TE; Collard HR
    Ann Intern Med; 2012 May; 156(10):684-91. PubMed ID: 22586007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
    Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity.
    Sverzellati N; Silva M; Seletti V; Galeone C; Palmucci S; Piciucchi S; Vancheri C; Poletti V; Tomassetti S; Karwoski R; Bartholmai BJ
    Eur Radiol; 2020 May; 30(5):2669-2679. PubMed ID: 32006172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly defined acute exacerbation of idiopathic pulmonary fibrosis with surgically-proven usual interstitial pneumonia: risk factors and outcome.
    Okuda R; Hagiwara E; Katano T; Ikeda S; Sekine A; Kitamura H; Baba T; Okudela K; Ohashi K; Ogura T
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(1):39-46. PubMed ID: 32476935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated airway quantification associates with mortality in idiopathic pulmonary fibrosis.
    Cheung WK; Pakzad A; Mogulkoc N; Needleman S; Rangelov B; Gudmundsson E; Zhao A; Abbas M; McLaverty D; Asimakopoulos D; Chapman R; Savas R; Janes SM; Hu Y; Alexander DC; Hurst JR; Jacob J
    Eur Radiol; 2023 Nov; 33(11):8228-8238. PubMed ID: 37505249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups.
    Kim GHJ; Weigt SS; Belperio JA; Brown MS; Shi Y; Lai JH; Goldin JG
    Eur Radiol; 2020 Feb; 30(2):726-734. PubMed ID: 31451973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
    Callahan SJ; Xia M; Murray S; Flaherty KR
    Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease progression in idiopathic pulmonary fibrosis without pulmonary function impairment.
    Kondoh Y; Taniguchi H; Ogura T; Johkoh T; Fujimoto K; Sumikawa H; Kataoka K; Baba T; Colby TV; Kitaichi M
    Respirology; 2013 Jul; 18(5):820-6. PubMed ID: 23489318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.